Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gerard

Showing results (271-280 of 307) with videos related to

Pageof 31
Sort By:
Science Advances|December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survivalMichael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
Epilepsia|March 11, 2004
Evidence for linkage between juvenile myoclonic epilepsy-related idiopathic generalized epilepsy and 6p11-12 in Dutch familiesDalila Pinto, Gerrit-Jan de Haan, Guus A M A J Janssen, et al.
Nature Immunology|February 2, 2016
CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursorsLokesh A Kalekar, Shirdi E Schmiel, Sarada L Nandiwada, et al.
Nature|July 22, 2014
PVT1 dependence in cancer with MYC copy-number increaseYuen-Yi Tseng, Branden S Moriarity, Wuming Gong, et al.
The Journal of Biological Chemistry|June 3, 2005
(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-GAndrew K P Taggart, Jukka Kero, Xiaodong Gan, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2010
Anthranilic acid replacements in a niacin receptor agonistDarby Schmidt, Abigail Smenton, Subharekha Raghavan, et al.
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109AHong C Shen, Michael J Szymonifka, Divya Kharbanda, et al.
Pageof 31

Showing results (271-280 of 307) with videos related to

Sort By:
Pageof 31
Science Advances|December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survivalMichael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
Epilepsia|March 11, 2004
Evidence for linkage between juvenile myoclonic epilepsy-related idiopathic generalized epilepsy and 6p11-12 in Dutch familiesDalila Pinto, Gerrit-Jan de Haan, Guus A M A J Janssen, et al.
Nature Immunology|February 2, 2016
CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursorsLokesh A Kalekar, Shirdi E Schmiel, Sarada L Nandiwada, et al.
Nature|July 22, 2014
PVT1 dependence in cancer with MYC copy-number increaseYuen-Yi Tseng, Branden S Moriarity, Wuming Gong, et al.
The Journal of Biological Chemistry|June 3, 2005
(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-GAndrew K P Taggart, Jukka Kero, Xiaodong Gan, et al.
The Journal of Biological Chemistry|April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectorsJeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2010
Anthranilic acid replacements in a niacin receptor agonistDarby Schmidt, Abigail Smenton, Subharekha Raghavan, et al.
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
Cancer Immunology Research|November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109AHong C Shen, Michael J Szymonifka, Divya Kharbanda, et al.
Pageof 31